Cotellic (cobimetinib) - Important Safety Information from Roche Products (Ireland) Ltd. as approved by the HPRA

Notice type: 3rd Party Publications

Date: 24/04/2017

 

Problem Or Issue:
Important Safety Information communication from Roche Products (Ireland) Ltd. - Important additional warnings for hemorrhage and rhabdomyolysis with Cotellic (cobimetinib), including new dose modification recommendations.

Important Safety Information - Cotellic (cobimetinib)
 


« Back